StockData
Inhibitor Therapeutics, Inc. logo

Inhibitor Therapeutics, Inc. (INTI) stock

INTIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$0.11+0.00 (+0.09%)

Close on Oct 19, 2026Market cap $19.06MP/E –Yield –

Inhibitor Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Inhibitor Therapeutics's total debt was $47.83K at Jun 30, 2026. For fiscal 2025 it was $61.61K.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$61.61K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$47.83K-38.7%
Q1 FY2026Mar 31, 2026$58.36K-30.8%
Q4 FY2025Dec 31, 2025$61.61K–
Q3 FY2025Sep 30, 2025$71.64K–
Q2 FY2025Jun 30, 2025$78.05K–
Q1 FY2025Mar 31, 2025$84.35K–

More Inhibitor Therapeutics figures

See a number that looks wrong?